Ticker Details
Structure Therapeutics Inc.
IPO Date:	February 3, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.91B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.18 | 3.21%
Avg Daily Range (30 D):	$1.50 | 2.80%
Avg Daily Range (90 D):	$2.06 | 3.46%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	.94M
Avg Daily Volume (90 D):	1.2M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	2,220
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$1.97M
Avg Institutional Trade (90 D):	$2.71M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.94M
Avg Closing Trade (30 D):	$3.03M
Avg Closing Trade (90 D):	$5.07M
Avg Closing Volume:	47.52K

News

Mar 16, 2026 @ 11:00 AM Structure Therapeutics Reports Positive Topline Da... Source: Structure Therapeutics Inc.

Feb 26, 2026 @ 6:35 PM PatentVest Releases New Report on The Oral Small-M... Source: Patentvest

Jan 23, 2026 @ 2:18 PM Weight Loss Drugs Market Is Crowded But Structure ... Source: Vandana Singh

Jan 13, 2026 @ 7:33 PM A 10% Owner Of Structure Therapeutics Shed Shares Source: Adé Hennis

Dec 10, 2025 @ 4:15 AM Structure Therapeutics Announces Pricing of Upsize... Source: Structure Therapeutics Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.8	$.2	$-.8
Diluted EPS	$-.8	$.2	$-.8
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-141.2M	$33M	$-141.2M
Operating Income / Loss	$-176.56M	$23.99M	$-176.56M
Cost of Revenue
Net Cash Flow	$630.11M	$696.71M	$630.11M
PE Ratio